Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease
(2023). Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease. EKB Journal Management System, 3(1), -. doi: 10.21608/esdlj.2023.456143
. "Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease". EKB Journal Management System, 3, 1, 2023, -. doi: 10.21608/esdlj.2023.456143
(2023). 'Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease', EKB Journal Management System, 3(1), pp. -. doi: 10.21608/esdlj.2023.456143
Assessment of Body Fat Distribution and Serum Liver-Type Fatty Acid-Binding Protein (L-FABP) and Neutrophil Gelatinase-Associated Lipocalin (NGAL): Potential Noninvasive Markers for Non-Alcoholic Fatty Liver Disease. EKB Journal Management System, 2023; 3(1): -. doi: 10.21608/esdlj.2023.456143